#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

Physicians asked. #ShockwaveC2Aero# delivered. ✔️ We're excited to announce that #ShockwaveC2Aero# is now available in Canada. Built to address real-world needs in deliverability, lesion crossing, and balloon repositioning, it reflects our ongoing commitment to redefining what's possible with #CoronaryIVL#. Learn more about #ShockwaveC2Aero#:  US Rx only. Safety Info: Product availability may vary by country.

🚀 First case. New possibilities. #ShockwaveC2Aero# now in Poland. Join us on 19-20 June at the 2nd Kashubian-Pomeranian Interventional Cardiology Workshop to explore insights from the first Shockwave C2 Aero case in Poland and discuss how this technology is advancing calcium modification in clinical practice. Ready to rethink calcium treatment? Let’s take on the toughest lesions, together. Register now: US Rx only. Safety Info: ​Product availability may vary by country.

What difference can better trackability make in the cath lab? ▶️ Watch Prof. Dr. Med. Michael Haude’s testimony on his first experience using #ShockwaveC2Aero#. The improved trackability helped Prof. Haude navigate tighter lesions more easily, while enhanced emitter visibility provided greater confidence throughout the procedure. Additionally, the shortened interval between every ten pulse deliveries, now reduced to just 5 seconds, contributed to a smoother workflow. At Shockwave, we are committed to advancing technologies that support physicians treating calcified lesions. Congratulations to Prof. Dr. Med. Haude on this amazing first case using Shockwave C2 Aero. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Trackability# Prof. Dr. Med. Michael Haude is a paid consultant for Shockwave Medical. Compared to Shockwave C2+ device. US Rx only. Safety Info:  Product availability may vary by country.

What if you could cross a tight calcified lesion without aggressive pre-dilatation? ▶️ Watch Dr. Gabriele Gasparini share how #ShockwaveC2Aero# supported his procedure, enabling him to start therapy delivery from proximal to distal in a challenging calcified lesion. Thanks to the catheter's crossability and trackability, lesion access was achieved without the need for excessive force, helping facilitate therapy delivery when it mattered most. We are proud to partner with physicians tackling some of the most complex calcified lesions every day. Congratulations to Dr Gasparini on this outstanding results. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Crossability# Dr Gabriele Gasparini is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

When treating challenging calcified nodules, Shockwave C2 Aero delivers ▶️ Watch Dr Nieves Gonzalo share her experience using #ShockwaveC2Aero# in a patient with a calcified nodule in the ostial and mid LAD. Learn how the device's enhanced crossability and catheter rewrap capability provided the flexibility to navigate the procedure with confidence and re-advance when needed. We're honored to be part of cases that help physicians address complex coronary calcified lesions and advance patient care every day. Congratulations to Dr Gonzalo on this successful treatment. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #CalcifiedNodule# Dr Nieves Gonzalo is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

Just like the leaves, we're going red this fall. 🍁 On October 1st, we're rebranding from Shockwave Medical to Johnson & Johnson MedTech and our portfolio will be known as circulatory restoration solutions. Our safe, effective technology will still be called #ShockwaveIVL#, and our product names — like #ShockwaveC2Aero# — are staying the same.

A tortuous, heavily calcified RCA. Multiple calcium morphologies. Complex PCI decision-making. Watch Dr. Allen Jeremias (@DrAllenJ) and Dr. Lindsey Cilia (@lindsey_cilia) break down a real-world case and discuss how #ShockwaveC2Aero# performed, including insights on deliverability, imaging, procedural efficiency, and treatment strategy. Explore the full interview and case walkthrough at Dr. Jeremias and Dr. Cilia are paid consultants of Shockwave Medical. US Rx only. Safety Info: Product availability may vary by country.

Same spark, new shade of bold. On October 1st, we'll officially shift from Shockwave Medical blue to Johnson & Johnson MedTech red and you'll start to see our entire portfolio referred to as circulatory restoration solutions. Our calcium-cracking technology will still be known as #ShockwaveIVL# and our product names — like #ShockwaveC2Aero# — won't be changing.

We're making waves at SOLACI 2026 in São Paulo, Brazil 🌊 ✅Training Village ✅National Live Case ✅Thematic session We're all set for Latin America's premier gathering for interventional cardiology, bringing together experts committed to advancing patient care through education, collaboration, and innovation. We can't wait to connect and introduce you to the new Shockwave C2 Aero. Até lá! 👋 #SOLACI2026# #ShockwaveIVL# #InterventionalCardiology# #ShockwaveC2Aero# #LiveCase# Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.